GSE206959 reserpine 2 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE206959_reserpine_2_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE206959_reserpine_2_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE206959_reserpine_2_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE206959_reserpine_2_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

maternally expressed 3

Gene

PAX8 antisense RNA 1

Gene

long intergenic non-protein coding RNA 1291

Gene

FSHD region gene 1 family member C, pseudogene

Gene

uncharacterized LOC339260

Gene

firre intergenic repeating RNA element

Gene

WAP four-disulfide core domain 21, pseudogene

Gene

prostate cancer associated transcript 7

Gene

RRN3 pseudogene 1

Gene

TSPEAR antisense RNA 1

  • Gene

    maternally expressed 3


  • Gene

    PAX8 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 1291


  • Gene

    FSHD region gene 1 family member C, pseudogene


  • Gene

    uncharacterized LOC339260


  • Gene

    firre intergenic repeating RNA element


  • Gene

    WAP four-disulfide core domain 21, pseudogene


  • Gene

    prostate cancer associated transcript 7


  • Gene

    RRN3 pseudogene 1


  • Gene

    TSPEAR antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.